US 11,717,549 B2
Steviol glycoside solubility enhancers
Dan S. Gaspard, Victoria, MN (US); and Adam T. Zarth, St. Louis Park, MN (US)
Assigned to CARGILL, INCORPORATED, Wayzata, MN (US)
Filed by CARGILL, INCORPORATED, Wayzata, MN (US)
Filed on Apr. 2, 2019, as Appl. No. 16/373,206.
Application 16/373,206 is a continuation of application No. PCT/US2018/054691, filed on Oct. 5, 2018.
Claims priority of provisional application 62/569,279, filed on Oct. 6, 2017.
Claims priority of provisional application 62/676,722, filed on May 25, 2018.
Prior Publication US 2019/0223481 A1, Jul. 25, 2019
Int. Cl. A23L 2/60 (2006.01); A23L 27/30 (2016.01); A61K 36/28 (2006.01); A23L 2/56 (2006.01); C07H 15/256 (2006.01); C07K 1/18 (2006.01); C07K 1/16 (2006.01); A23L 2/68 (2006.01); A23L 27/00 (2016.01); A23L 5/40 (2016.01); A23F 3/34 (2006.01); A61K 31/192 (2006.01); A61K 31/235 (2006.01); B01D 15/36 (2006.01)
CPC A61K 36/28 (2013.01) [A23F 3/34 (2013.01); A23L 2/56 (2013.01); A23L 2/60 (2013.01); A23L 2/68 (2013.01); A23L 5/40 (2016.08); A23L 27/30 (2016.08); A23L 27/36 (2016.08); A23L 27/39 (2016.08); A23L 27/88 (2016.08); A61K 31/192 (2013.01); A61K 31/235 (2013.01); B01D 15/361 (2013.01); C07H 15/256 (2013.01); C07K 1/16 (2013.01); C07K 1/18 (2013.01); A23V 2002/00 (2013.01); A23V 2200/15 (2013.01); A23V 2250/258 (2013.01); A61K 2236/31 (2013.01); A61K 2236/39 (2013.01)] 16 Claims
 
1. An aqueous steviol glycoside solution comprising:
a) greater than 0.2% by weight of a total steviol glycoside composition comprising one or more steviol glycosides, wherein if the steviol glycoside composition includes rebaudioside A, rebaudioside D, or rebaudioside M, the rebaudioside A individual concentration in the aqueous steviol glycoside solution is at least 1% by weight, the rebaudioside D individual concentration in the aqueous steviol glycoside solution is at least 0.2% by weight, or the rebaudioside M individual concentration in the aqueous steviol glycoside solution is at least 0.3% by weight;
b) less than 0.3% by weight of malonate, malonic acid, oxalate, oxalic acid, lactate, lactic acid, succinate, succinic acid, malate, or malic acid; or less than 0.05% by weight of pyruvate, pyruvic acid, fumarate, fumaric acid, tartrate, tartaric acid, sorbate, sorbic acid, acetate, or acetic acid; or less than about 0.05% by weight of chlorophyll; and
c) at least 1% by weight of a steviol glycoside solubility enhancer composition comprising
i) one or more monocaffeoylquinic acids or salts thereof;
ii) at least 20% by weight of one or more dicaffeoylquinic acids or salts thereof; and
iii) at least one of an ester of ferulic acid and quinic acid, an ester of caffeic acid and tartaric acid, an ester of caffeic acid and 3-(3,4-dihydroxyphenyl)lactic acid, an ester of p-coumaric acid and quinic acid, an ester of sinapic acid and quinic acid, and isomers thereof;
wherein the aqueous steviol glycoside solution comprises a 1:0.3 to 1:3 ratio by weight of total steviol glycoside to steviol glycoside solubility enhancer composition.